You just read:

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

News provided by

CardioVascular BioTherapeutics, Inc.

Feb 03, 2011, 07:30 ET